Construction and validation of a Biological Sample Quality Management System for Multicenter Clinical Research of Cerebrovascular Diseases
LIN Jinxi1,2,3, LI Shangzhi1,2, WANG Mengxing1,2, MENG Xia1,2,3
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
2 China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
3 Center of Stroke, Beijing Institute of Brain Disorders, Beijing 100070, China
LIN Jinxi, LI Shangzhi, WANG Mengxing, MENG Xia. Construction and validation of a Biological Sample Quality Management System for Multicenter Clinical Research of Cerebrovascular Diseases[J]. Chinese Journal of Stroke, 2025, 20(12): 1576-1582.
[1]林金嬉,梁宪红,李上智,等. 脑血管病生物样本库建设标准研究[J]. 中国卒中杂志,2021,16(5):449-456.
LIN J X,LIANG X H,LI S Z,et al. Research on standard for construction of cerebrovascular disease biobank[J]. Chin J Stroke,2021,16(5):449-456.
[2] 林金嬉,梁宪红,李上智,等. 中国脑血管病多中心临床研究生物样本库建设模式探讨[J]. 中国卒中杂志,2021,16(6):567-573.
LIN J X,LIANG X H,LI S Z,et al. Exploring the construction model of multi-center clinical research biobank for cerebrovascular disease in China[J]. Chin J Stroke,2021,16(6):567-573.
[3] 国务院. 中华人民共和国人类遗传资源管理条例[EB/OL].(2019-06-10)[2025-09-01]. https://www.gov.cn/zhengce/content/2019-06/10/content_5398829.htm.
[4] 国家卫生健康委员会科技教育司. 关于医疗卫生机构科研用人类生物样本管理暂行办法(征求意见稿)公开征求意见的公告[EB/OL].(2022-01-29)[2025-09-01]. https://www.nhc.gov.cn/qjjys/c100016/202201/5ca33c485e0b4683b049c4a89e9d994f.shtml.
[5] 国家市场监督管理总局,中国国家标准化管理委员会. 生物样本库质量和能力通用要求[EB/OL].(2019-08-30)[2025-09-01]. https://openstd.samr.gov.cn/bzgk/gb/newGbInfo?hcno=4FCF97DA42C358B2E83735834928F512.
[6] 北京市市场监督管理局. 临床生物样本库运行质量技术要求[EB/OL].(2024-09-23)[2025-09-01]. https://www.spc.org.cn/online/c625d67ec9d7610b35a61ed702664a80.html.
[7] International Society for Biological and Environmental Repositories. 2012 best practices for repositories collection,storage,retrieval,and distribution of biological materials for research international society for biological and environmental repositories[J]. Biopreserv Biobank,2012,10(2):79-161.
[8] TREHEARNE A. Genetics,lifestyle and environment. UK biobank is an open access resource following the lives of 500 000 participants to improve the health of future generations[J]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,2016,59(3):361-367.
[9] TAMMINEN S. Bio-objectifying European bodies:standardisation of biobanks in the biobanking and biomolecular resources research infrastructure[J/OL]. Life Sci Soc Policy,2015,11:13[2025-09-01]. https://doi.org/10.1186/s40504-015-0031-1.
[10] NORLIN L,FRANSSON M N,ERIKSSON M,et al. A minimum data set for sharing biobank samples,information,and data:MIABIS[J]. Biopreserv Biobank,2012,10(4):343-348.
[11] MERINO-MARTINEZ R,NORLIN L,ENCKEVORT D V,et al. Toward global biobank integration by implementation of the minimum information about biobank data sharing(MIABIS 2.0 core)[J]. Biopreserv Biobank,2016,14(4):298-306.
[12] National Institute of Mental Health. Notice of biospecimen sharing policy for the National Institute of Mental Health,including requirements for induced pluripotent stem cell resource development and sharing[EB/OL].(2021-06-11)[2025-09-01]. https://www.grants.nih.gov/grants/guide/notice-files/NOT-MH-21-265.html.
[13] OH S W,KIM K,IM Y S,et al. Development and evaluation of a data quality management system for the Korea Biobank Network[J/OL]. Stud Health Technol Inform,2024,316:237-241[2025-09-01]. https://doi.org/10.3233/SHTI240389.
[14] LINSEN L,T’JOEN V,VAN DER STRAETEN C. et al. Biobank quality management in the BBMRI.be
network[J/OL]. Front Med(Lausanne),2019,6:141[2025-09-01]. https://doi.org/10.3389/fmed.2019.00141.
[15] LIU Y H,GAO H,HU Y,et al. Quality control system in an obstetrics and gynecology disease biobank[J]. Biopreserv Biobank,2019,17(1):27-38.
[16] 张允,李秀红,张璇,等. 临床生物样本的过程质量监控[J]. 临床和实验医学杂志,2015,14(21):1755-1757. ZHANG Y,LI X H,ZHANG X,et al. The process quality control of clinical biological specimen[J]. Journal of Clinical and Experimental Medicine,2015,14(21):1755-1757.